Nurse Practitioner Chronicles

 COLORECTAL CANCER SCREENING UPDATE | CLINICAL PRACTICE SERIES June 2026 | NP Chronicles Clinical Education The ACS Just Updated Its Colorectal Cancer Screening Guideline. Here’s What NPs Need to Know. By Valerie Watters-Burke, DNSc, MSN, MBA, FNP-BC, GNP-BC, PPCNP-BC On stool-based molecular testing, blood-based screening, and why “the best test” is still the one the patient actually completes CLINICAL AND PROFESSIONAL BOTTOM LINE The 2026 American Cancer Society colorectal cancer screening guideline does not change the core age recommendations: average-risk adults should still begin screening at age 45, continue through age 75 if life expectancy is greater than 10 years, individualize screening decisions from ages 76 to 85, and generally stop screening after age 85. What is new is the screening menu. The ACS now recognizes newly approved molecular stool-based tests — including the multitarget stool RNA test and next-generation multitarget stool DNA test — as prefer...

  NFECTIOUS DISEASE   |   STI PREVENTION & SEXUAL HEALTH June 2026   |   NP Chronicles Clinical Education   DoxyPEP in 2026: What Every NP Needs to Know About Prescribing, Patient Selection, and Antibiotic Stewardship By Valerie Watters-Burke, DNSc, MSN, MBA, FNP-BC, GNP-BC, PPCNP-BC Based on: Bacic Lima D. DoxyPEP in 2026: Who Benefits, How to Prescribe, and What to Watch. Infectious Disease Special Edition. April 23, 2026. idse.net   CLINICAL BOTTOM LINE DoxyPEP — doxycycline 200 mg taken within 72 hours after unprotected sexual exposure — is now CDC-endorsed, evidence-backed, and increasingly part of routine STI prevention practice for MSM and transgender women who have sex with men. NPs in primary care, sexual health, family practice, telehealth, and urgent care settings are encountering patients who have already heard of it and want to discuss it. This post gives you everything you need: the trial data, candidacy crit...